Neurodevelopmental disorders- Lucky Dip Flashcards

(12 cards)

1
Q

What is the relationship between the levels of brain-derived neurotrophic factor (BDNF) and ASD?

A

A systematic review and meta-analysis found that individuals with ASD tend to have lower levels of BDNF compared to neurotypical individuals

Rylaarsdam and Guemez-Gamboa 2019

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the role of sex hormones in autism spectrum disorder (ASD) pathology?

Explain the potential role of sex hormones in the pathology of Autism Spectrum Disorder (ASD).

A
  • Sex differences in ASD
  • Testosterone influences dendritic spine density
  • Estrogen recovers ASD phenotypes in animal models
  • Testosterone and estrogen differently modulate immune system in ASD

Rylaarsdam and Guemez-Gamboa 2019

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are brain organoids, and how are they utilized in ASD research?

A

Brain organoids are three-dimensional cell cultures derived from human stem cells that mimic the development of the human brain

hCOs and hFAs used to investigate specific genetic mutations and cellular/molecular mechanisms in autism and use the model for drug testing/development
- Eg one group recently used SNR-derived organoids to study SHANK3, organoids are functionally mature and capable of generating various electrical signals and oscillatory rhythms
- Eg used to study Timmothy syndrome (gain of function mutation in CACNA1C gene encoding CaV1.2) and investigate cellular/molecular mechanisms
- Eg can be transplanted into neonatal rat brains to investigate circuit formation in Timmothy syndrome and was used to test antisense oligonucleotide as a therapy

human cortical organoids (hCO) and forebrain assembloids (hFA)

Studies using iPSC-derived neurons from individuals with TS1 in both two- and three-dimensional cultures reported delayed voltage-dependent channel inactivation and increased depolarization-induced calcium entry, leading to abnormal excitability

Transplanting human cortical organoids was crucial for revealing TS disease phenotypes that were not apparent in in vitro organoids and for testing potential therapies (altered dendritic morphology, inc synaptic spine density, inc EPSC frequency, all were gone after ASO treatment)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How are SNR-derived organoids used to study ASD?

single neural rosettes= SNR

A
  • SNRs are self-organized structures derived from stem cells; very similar organization and properties of anterior neural tube cells
  • Used to study SHANK3 deletion (causes ASD)
  • Generate many cell types: 1) neural progenitors, 2) excitatory/inhibitory interneurons 3) excitatory/inhibitory neurons
  • In this study, telencephalic identity was confirmed with FOXG1 and absense of markers for other germ layers or brain regions

Wang et al., 2022

this study validates SNR-derived organoids as a model for studying brain development
This study identifies intrinsic, synaptic, and clustered protocadherin expression deficits in human telencephalic tissue with SHANK3 hemizygosity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Explain the significance of GSX2 expression in the context of brain organoid research and ASD

A
  • Transcription factor GSX2 appears to be crucial for the specification of inhibitory neurons, specifically inhibitory striatal projection neurons (ISPNs), a cell type previously not observed in some telencephalic organoid models, and was was observed in SNR-derived organoids
  • Relevant because imbalances in excitatory/inhibitory (E/I) signaling have been implicated in ASD.
  • The presence of GSX2-expressing neural progenitors in organoids may contribute to the successful generation of ISPNs
  • By manipulating GSX2 expression in organoid models, researchers can gain a deeper understanding of its impact on neuronal differentiation, circuit formation, and ultimately, the development of ASD phenotypes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Discuss the role of the SHANK3 gene in ASD and how its deficiency is modeled in brain organoids

A
  • SHANK3 cruical protein regulating post synaptic density, and its deletion underlies ASD pathology
  • SHANK3 deficiency (hemizygous +/-) is modeled in brain organoids (SNR) by using CRISPR/Cas9
  • This allows researchers to study the effects of SHANK3 loss on neuronal development and function:
  • Found 1) synaptic deficits, 2) neuronal hyperexcitability and 3) impaired clustered protocadherin expression

Wang et al 2022

synaptic gene deletions can disrupt the development and function of synapses, leading to alterations in neural circuitry and ultimately contributing to the behavioral and cognitive symptoms of ASD.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the electrophysiological differences observed between iCtrl and SHANK3-deficient neurons in brain organoids?

A

One study found that SHANK3-deficient neurons exhibit increased excitability compared to control neurons.
- shorter action potential latency
- smaller membrane capacitance
- more hyperpolarized action potential threshold
- reduced afterhyperpolarization potential amplitude
- increased firing rate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Explain how targeted DNA methylation of the Mecp2 promoter is achieved and its implications for understanding ASD

A

Targeted methylation leads to gene silencing, allowing researchers to study the impact of Mecp2 downregulation on neuronal function and ASD-like phenotypes in animal models.
- one study used dCas9-DNMTA3 to target DNA methylation of the Mecp2 promoter
- This system involves fusing the DNA methyltransferase DNMT3A to a catalytically inactive Cas9 (dCas9) guided by specific sgRNAs to the Mecp2 promoter region.

Lu et al 2020

Mecp2 loss of function mutation= Rett syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Discuss the rationale for targeting mGluR7 as a potential therapeutic target in Rett Syndrome.

A

Targeting mGluR7, a metabotropic glutamate receptor, is proposed as a potential therapeutic strategy in Rett Syndrome based on the finding that **its function is impaired in Mecp2-deficient models. **

Enhancing mGluR7 activity with positive allosteric modulators like VU0422288 has shown promise in rescuing synaptic plasticity defects and improving behavioral phenotypes associated with Rett Syndrome in preclinical studies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Explain the role of the MECP2 gene in Rett Syndrome

A

MECP2 causes Rett syndrome, located on X chromosome and necessary for brain development, regulates expression of a variety of developmental genes

Oluigbo 2023

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the current therapeutic strategies for Timothy Syndrome?

A

antisense oligonucleotides (ASOs) re synthetic molecules that can specifically target and modify RNA, they can be engineered to inhibit exon 8A in the CACNA1C gene CACNA1C and restore normal Ca2+ channel function

Timothy Syndrome, a rare genetic disorder characterized by heart defects, autism, long QT syndrome, and distinctive facial features, is caused by enhanced splicing of exon 8A in the CACNA1C gene, which encodes L-type calcium channel.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the current therapies for Rett syndrome:

A

None rn
in 2023 FDA approved: Trofinetide (Daybue): synthetic analog of glycine-proline-glutamate (GPE), a naturally occurring protein in the brain that has previously improved motor and respiratory function, increased IGF-1 and reduced inflammation in humans

How well did you know this?
1
Not at all
2
3
4
5
Perfectly